Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
Journal article published in 2022 by
Kevin K. Ariën 
,
Leo Heyndrickx,
Johan Michiels,
Katleen Vereecken,
Kurt Van Lent,
Sandra Coppens,
Betty Willems,
Pieter Pannus ,
Geert A. Martens ,
Marjan Van Esbroeck ,
Maria E. Goossens,
Arnaud Marchant,
Koen Bartholomeeusen,
Isabelle Desombere
,
Leo Heyndrickx,
Johan Michiels,
Katleen Vereecken,
Kurt Van Lent,
Sandra Coppens,
Betty Willems,
Pieter Pannus ,
Geert A. Martens ,
Marjan Van Esbroeck ,
Maria E. Goossens,
Arnaud Marchant,
Koen Bartholomeeusen,
Isabelle Desombere
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 
Abstract
AbstractWe report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.